Navigation Links
ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
Date:8/19/2007

San Francisco Office Doubles Staff; San Diego Office to Offer Regulatory

Operations Expertise

WHIPPANY, N.J., Aug. 15 /PRNewswire/ -- Image Solutions, Inc. (ISI), a leader in providing software and services to streamline the drug development lifecycle, today announced the expansion of its San Francisco office and opening of a new facility in San Diego. The announcements illustrate the company's newly elevated focus on emerging West Coast biotechnology, pharmaceutical and Life Sciences companies, and solidify its position as a local strategic partner for companies that require support for regulatory operations and go-to-market strategies designed to expedite the approval of new medicines.

"California is a hotbed for innovation in the Life Sciences industry because of the state government's support and the community's focus on fostering scientific breakthroughs," said Jinsoo Kim, founder, president and chief executive officer. "We are well positioned to serve this market and look forward to expanding our existing customer base throughout the state."

The biotechnology industry in California is supported by state legislation and a local infrastructure that provides support for its growth, including local academic institutions, venture capital pools for emerging companies, incubators, and large pharmaceutical companies. ISI's San Francisco office has benefited from these conditions for three years, triggering the company to hypothesize that other parts of the state hold promise as well. In San Diego, there are currently 500 companies employing more than 6,600 employees in emerging technology industries. The San Diego Association of Governments estimates that these companies have an annual economic impact of $8.5 billion.

A June 2007 focus group in San Diego supported ISI's contention that there was a strong market demand for flexibly packaged offerings. One of the chief findings was that emerging Life Sciences firms are fundamentally interested in packages that provide document management and electronic regulatory submission tools that can grow with their needs and future business plans, and outsourcing support that can help them meet major submission milestones. Given this feedback - as well as additional research on the typical stage and phase of products these companies have in development that dovetail perfectly with ISI's core offerings - the California investments made perfect sense.

"Through our research, we've learned that many emerging companies may not have the regulatory or IT support to prepare for some of the new regulations," said Sue Simpson, managing director of West Coast operations for ISI. "These companies' regulatory support staff generally is limited to one person who may need help understanding the challenges inherent to drug development, compliance and validation. ISI is helping to fill that knowledge gap by providing software and regulatory guidance to help steer these companies through the process."

To address the need for compliance support, ISI has announced two additions to their California regulatory staff: Annette Nilsen, senior regulatory consultant; and Sunshine Bruce, regulatory consultant. Nilsen possesses nine years experience in publishing paper and electronic new drug submissions as well as seven years project management experience with top pharmaceutical companies including Elan Pharmaceuticals and Pfizer, Inc. Nilsen will be working from the San Diego office. Bruce previously was employed by Allergan in the regulatory affairs group and possesses a wide range of business and technology skills. Bruce will be working from the San Francisco office.

ISI's West Coast services include regulatory operations and outsourcing capabilities and training, as well as regulatory consulting and staff augmentation. The office also supports software implementation, which is particularly important to emerging Life Sciences firms dealing with federal government-mandated standards. ISI's San Francisco office, which opened in 2004, relocated in August to accommodate the growing staff, now twice the size of the original team. The San Diego office opened July 1st. Both offices are supported by ISI's global team of 380 staff members.

ISI's industry leading solutions are pragmatic and scalable and take into consideration regulatory agencies in varying regions, and changing electronic submission requirements. Additionally, their portfolio of proven tools and templates supports these flagship products, eCTDXPress(R), an automated regulatory submission system that meets the FDA's electronic Common Technology Document (eCTD) standard and ISIPublisher(R), a multi-format publishing system for international regulatory submissions. Both products are further enhanced through a flexible technology foundation: the ISI Solutions Platform, a Microsoft's .NET architecture that provides a reliable foundation for integration and interoperability. Over the past several years .NET has demonstrated an ability to help Life Science organizations reduce costs through faster integration and improve quality while streamlining their drug development lifecycle.

About Image Solutions

Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered nearly 1,000 electronic submissions and over 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations. For more information, visit the company website at http://www.imagesolutions.com.

Press Contacts:

Lisa Meyer Kurt Rossler

Director, Global Marketing M Booth & Associates

973-560-0808 x. 217 212 481-7000

lisa.meyer@imagesolutions.com kurtr@mbooth.com


'/>"/>
SOURCE Image Solutions, Inc.

Copyright©2007 PR Newswire.

Related biology technology :

1. Renaissance Learning increases net, still plans merger
2. Johnson Controls weathers auto market and increases sales
3. Alfalight increases laser efficiency for DOD program
4. Business Plan Bounty Increases to $105,000
5. Investor links East Coast funds to Midwest tech
6. Third coast of biotechnology makes strong showing at VC conference
7. Wisconsin entrepreneurs need to self-promote like coastal rivals
8. Americas Third Coast nurtures biotechnology
9. West Coast VC Establishes Midwest Presence in Madison
10. Advantages of Roche Applied Science amplification products
11. Tools for Proteomic Science II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):